We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Ellyn Sternfield

Mintz

Results 1 to 5 of 99
Most popular |Most recent


Corporate grief: the six stages of coping with a reported compliance problem

USA - March 12 2015 When a company first learns of a reported compliance problem, the reaction of management will likely fluctuate from disbelief, to swearing they were...

Lauren Moldawer.


Health Care Qui Tam Update

USA - November 5 2018 In this issue, we provide an overview of 62 recently unsealed qui tam cases and take an in-depth look at four of those cases. Two of the featured...

Benjamin M. Zegarelli, Kevin M. McGinty, Hope S. Foster.


Five Things to Know About the Mylan EpiPen “Settlement” - What It Is and What It Isn’t

USA - October 14 2016 Our eyebrows were raised by Mylan’s October 7, 2016 announcement that it had reached a $465 million “settlement” with the United States Department of...

Rodney L. Whitlock.


The Four Things That Surprised Us in the EpiPen False Claims Settlement

USA - August 23 2017 On August 17, 2017, the U.S. Department of Justice (DOJ) announced that it had reached a $465 million false claims settlement with Mylan, the...

Rodney L. Whitlock.


This Year May be a Game Changer for 340B B Drug Discount Program, Take Two

USA - January 17 2018 I previously said that the year 2014 may be a game-changer for the 340B Drug Discount Program. Increasing HRSA audits, a lawsuit over the 340B Orphan...